![](/fileadmin/_processed_/6/3/csm_Team_Martin_Goette_fcef9b331f.jpg)
![](/fileadmin/_processed_/d/8/csm_Geb%C3%A4ude_AFK_Kliesch_830aa9df19.jpg)
![](/fileadmin/_processed_/1/7/csm_WWU_Figure_Science_30f48aa899.jpg)
Key publications
Ibrahim SA et al. MicroRNA regulation of proteoglycan function in cancer. FEBS J. 2014, 281:5009-22.
Vijaya Kumar A et al. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression. Int J Cancer. 2014, 135:2579-92.
Ibrahim SA et al. MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior. Biochim Biophys Acta. 2014, 1840:2609-20.
Hassan H et al. Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation. FEBS J. 2013;280:2216-27.
Ibrahim SA et al. Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS One. 2013;8:e85737
Ibrahim SA et al. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism. Int J Cancer. 2012;131:E884-96.
Nikolova V, et al. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis. 2009;30:397-407.
Vijaya Kumar A et al. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression. Int J Cancer. 2014, 135:2579-92.
Ibrahim SA et al. MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior. Biochim Biophys Acta. 2014, 1840:2609-20.
Hassan H et al. Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation. FEBS J. 2013;280:2216-27.
Ibrahim SA et al. Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS One. 2013;8:e85737
Ibrahim SA et al. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism. Int J Cancer. 2012;131:E884-96.
Nikolova V, et al. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis. 2009;30:397-407.
![](/fileadmin/einrichtung/glycanc/Unikliniken.jpg)